293 related articles for article (PubMed ID: 20187731)
21. Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians.
Jeanes YM; Barr S; Smith K; Hart KH
J Hum Nutr Diet; 2009 Dec; 22(6):551-8. PubMed ID: 19735349
[TBL] [Abstract][Full Text] [Related]
22. Endometrial Expression of Estrogen Receptors and the Androgen Receptor in Women With Polycystic Ovary Syndrome: A Lifestyle Intervention Study.
Hulchiy M; Nybacka Å; Sahlin L; Hirschberg AL
J Clin Endocrinol Metab; 2016 Feb; 101(2):561-71. PubMed ID: 26649621
[TBL] [Abstract][Full Text] [Related]
23. Lifestyle modification intervention among infertile overweight and obese women with polycystic ovary syndrome.
Mahoney D
J Am Assoc Nurse Pract; 2014 Jun; 26(6):301-8. PubMed ID: 24170708
[TBL] [Abstract][Full Text] [Related]
24. The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial.
Hiam D; Patten R; Gibson-Helm M; Moreno-Asso A; McIlvenna L; Levinger I; Harrison C; Moran LJ; Joham A; Parker A; Shorakae S; Simar D; Stepto N
Trials; 2019 Apr; 20(1):221. PubMed ID: 30992038
[TBL] [Abstract][Full Text] [Related]
25. Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych].
Dutkowska A; Konieczna A; Breska-Kruszewska J; Sendrakowska M; Kowalska I; Rachoń D
Endokrynol Pol; 2019; 70(2):198-212. PubMed ID: 31039273
[TBL] [Abstract][Full Text] [Related]
26. Obesity and lifestyle management in polycystic ovary syndrome.
Hoeger KM
Clin Obstet Gynecol; 2007 Mar; 50(1):277-94. PubMed ID: 17304042
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular risk in women with polycystic ovary syndrome.
Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
[TBL] [Abstract][Full Text] [Related]
28. Exercise decreases anti-müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: a pilot study.
Moran LJ; Harrison CL; Hutchison SK; Stepto NK; Strauss BJ; Teede HJ
Horm Metab Res; 2011 Dec; 43(13):977-9. PubMed ID: 21989557
[TBL] [Abstract][Full Text] [Related]
29. Assessing self-efficacy and self-help methods in women with and without Polycystic Ovary Syndrome.
Kozica SL; Gibson-Helm ME; Teede HJ; Moran LJ
Behav Med; 2013; 39(3):90-6. PubMed ID: 23930901
[TBL] [Abstract][Full Text] [Related]
30. Obesity and polycystic ovary syndrome.
Naderpoor N; Shorakae S; Joham A; Boyle J; De Courten B; Teede HJ
Minerva Endocrinol; 2015 Mar; 40(1):37-51. PubMed ID: 25411807
[TBL] [Abstract][Full Text] [Related]
31. Perceived exercise barriers are reduced and benefits are improved with lifestyle modification in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
Thomson RL; Buckley JD; Brinkworth GD
BMC Womens Health; 2016 Mar; 16():14. PubMed ID: 26960762
[TBL] [Abstract][Full Text] [Related]
32. Dietary therapy in polycystic ovary syndrome.
Moran LJ; Brinkworth GD; Norman RJ
Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
[TBL] [Abstract][Full Text] [Related]
33. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
[TBL] [Abstract][Full Text] [Related]
34. The role of lifestyle modification in polycystic ovary syndrome.
Norman RJ; Davies MJ; Lord J; Moran LJ
Trends Endocrinol Metab; 2002 Aug; 13(6):251-7. PubMed ID: 12128286
[TBL] [Abstract][Full Text] [Related]
35. [Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].
Feichtinger M; Stopp T; Göbl C
Wien Med Wochenschr; 2016 Mar; 166(3-4):139-42. PubMed ID: 26819214
[TBL] [Abstract][Full Text] [Related]
36. Metabolic health during a randomized controlled lifestyle intervention in women with PCOS.
Dietz de Loos A; Jiskoot G; Beerthuizen A; Busschbach J; Laven J
Eur J Endocrinol; 2021 Nov; 186(1):53-64. PubMed ID: 34714771
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping.
Caserta D; Adducchio G; Picchia S; Ralli E; Matteucci E; Moscarini M
Gynecol Endocrinol; 2014 Jun; 30(6):397-402. PubMed ID: 24552422
[TBL] [Abstract][Full Text] [Related]
38. Polycystic ovary syndrome.
King J
J Midwifery Womens Health; 2006; 51(6):415-22. PubMed ID: 17081931
[TBL] [Abstract][Full Text] [Related]
39. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.
Huber-Buchholz MM; Carey DG; Norman RJ
J Clin Endocrinol Metab; 1999 Apr; 84(4):1470-4. PubMed ID: 10199797
[TBL] [Abstract][Full Text] [Related]
40. Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome.
Roessler KK; Birkebaek C; Ravn P; Andersen MS; Glintborg D
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):272-7. PubMed ID: 23237575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
